Notes: October 2, 2017 -- EnteroMedics Inc., a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with ReShape Medical, Inc., a Delaware corporation (“ReShape”), Nixon Subsidiary Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”), Nixon Subsidiary Holdings LLC, a Delaware limited liability company and wholly owned subsidiary of the Company (“Sub LLC”), and HealthCor Partners Fund II, L.P. and Endeavour Medtech GP Limited, solely in their capacity as members of the committee (the “ReShape Holder Committee”) representing the ReShape stockholders and convertible promissory note holders receiving a portion of the merger consideration (the “ReShape Holders”). Pursuant to the Merger Agreement, among other things, Merger Sub initially merged with and into ReShape, with ReShape surviving as a wholly owned subsidiary of the Company (the “Merger”) and, subsequently, ReShape merged with and into Sub LLC, with Sub LLC as the surviving company and a wholly owned subsidiary of the Company. The Merger has been approved by the board of directors of the Company (the “Board”), by the boards of directors of Merger Sub and ReShape, by the sole member of Sub LLC, and by the stockholders of ReShape. ________________ December 28, 2016 -- EnteroMedics Inc. (ETRM) will effect a one-for-seventy (1-70) reverse split of its common stock. The CUSIP number will change to 29365M505._______________Jan. 7, 2015 -- EnteroMedics Inc. (ETRM) will effect a one-for-fifteen (1-15) reverse split of its Common Stock. The reverse split will be effective at the opening of business on Thursday, January 7, 2016. In conjunction with the reverse split, the CUSIP number will change to 29365M307.